Elephantiasis (Lymphatic Filariasis): Causes, Symptoms & Treatment Options

Elephantiasis is the dramatic late manifestation of lymphatic filariasis, a mosquito-borne parasitic disease caused by thread-like nematodes (Wuchereria bancrofti, Brugia malayi, B. timori). It affects an estimated 120 million people across 72 tropical and subtropical countries.

Pathogenesis

  • Mosquito deposits larvae → migrate to lymphatics → mature into adult worms (lifespan 5–10 years).
  • Adults cause lymphatic dilation, valve incompetence, and chronic inflammation → lymphatic dysfunction.
  • Impaired lymph drainage → protein-rich fluid accumulation → progressive swelling, fibrosis, and adipose hyperplasia.

Clinical Features

  • Lymphedema: Progressive, non-pitting swelling (legs, arms, scrotum, vulva, breast).
  • Skin changes: Thickening, hyperkeratosis, verrucous lesions ("mossy foot"), recurrent cellulitis.
  • Hydrocele: Scrotal swelling (common in males).
  • Acute attacks: Filarial fever, lymphangitis, painful adenolymphangitis (ADL).

Diagnosis

  • Microscopy: Night blood smear for microfilariae (nocturnal periodicity).
  • Antigen test (ICT card): Detects circulating filarial antigen (daytime, high sensitivity).
  • Ultrasound: "Filarial dance sign" (adult worms visualized in lymphatics).

Treatment

  • Mass Drug Administration (MDA): Annual albendazole + ivermectin (or DEC) to interrupt transmission (WHO strategy).
  • Individual treatment: DEC 6 mg/kg/day × 12 days (kills microfilariae & some adults); doxycycline 4–6 weeks (targets Wolbachia endosymbiont).
  • Lymphedema management: Hygiene, elevation, compression, exercise, skin care, antibiotics for acute attacks.
  • Surgery: Hydrocelectomy; debulking for advanced elephantiasis.

Global Goal

WHO targets elimination as a public health problem by 2030 through MDA, morbidity management, and disability prevention.

Blood Disorders - Related Articles